During the past decade, Lokmanya Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lokmanya Hospital" #1 sponsor was "Kowa Research Europe" with 2 trials, followed by "Eisai Inc." with 1 trials sponsored, "PUNEET MITTAL" with 1 trials sponsored, "Smith & Nephew, Inc." with 1 trials sponsored and "University of Sydney" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lokmanya Hospital" #1 collaborator was "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Australia & New Zealand Dialysis & Transplant Registry" with 1 trials as a collaborator, "Institute for Clinical Evaluative Sciences" with 1 trials as a collaborator, "Malaysian Renal Registry" with 1 trials as a collaborator and "Malaysian Society of Nephrology" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Lokmanya Hospital" are "Dyslipidemia" (2 trials), "Arthroplasty" (1 trials), "Breast Neoplasms" (1 trials), "End-Stage Kidney Disease" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Lokmanya Hospital" in a lesser frequency.

Most popular intervention types in "Lokmanya Hospital" are "Drug" (3 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pitavastatin" (2 trials), "Atorvastatin" (1 trials), "CORI Robotics" (1 trials), "Default dialysate sodium concentration of 137mmol/l" (1 trials) and "Default dialysate sodium concentration of 140mmol/l" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lokmanya Hospital" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lokmanya Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lokmanya Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lokmanya Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".